MedTrace Logo

Calmodulin Gene Mutations in Patients With Ventricular Arrhythmia of Unknown Origin - A Screening Study

NCT01947543 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2018-04-11

No results posted yet for this study

Summary

The aim of this study is to screen a well characterized patient population with ventricular tachycardia of unknown origin and treated with an implantable cardioverter-defibrillator (ICD) for mutations in the calmodulin genes.

Conditions

  • Ventricular Tachycardia

Sponsors & Collaborators

  • Region Örebro County

    lead OTHER

Principal Investigators

  • Ole Fröbert, MD, Ph.D. · Department of Cardiology, Örebro University Hospital, Örebro, Sweden

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-01-31
Primary Completion
2018-04-30
Completion
2018-04-30

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01947543 on ClinicalTrials.gov